TRIM21 and synovial sarcoma: Analysing 55 patients with SS, there was no association between the reactivity of anti-SSA/Ro52-/-SSA/Ro60- and -SSB/La-IgE antibodies and the number of organ manifestations, presence of sicca-syndrome, musculoskeletal, or cutaneous symptoms (Table 2A).